Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-01-16 | NGM BIOPHARMACEUTICALS INC | Lieu Hsiao D
(EVP, CHIEF MEDICAL OFFICER) |
F | Common Stock | D | 5430 | $1.34 - $1.34 | $7,276 |
| 2024-01-16 | NGM BIOPHARMACEUTICALS INC | Perlich Irene
(PRINCIPAL ACCOUNTING OFFICER) |
F | Common Stock | D | 1025 | $1.34 - $1.34 | $1,373 |
| 2024-01-16 | NGM BIOPHARMACEUTICALS INC | Pierce Valerie L
(SVP, GC & CCO) |
F | Common Stock | D | 5021 | $1.34 - $1.34 | $6,728 |
| 2024-01-16 | NGM BIOPHARMACEUTICALS INC | WOODHOUSE DAVID J
(CHIEF EXECUTIVE OFFICER) |
F | Common Stock | D | 13032 | $1.34 - $1.34 | $17,462 |
| 2023-11-15 | NGM BIOPHARMACEUTICALS INC | Column Group II G...
(AtLeastTenPercentOwner) |
P | Common Stock | A | 22631 | $0.62 - $0.71 | $15,506 |
| 2023-11-15 | NGM BIOPHARMACEUTICALS INC | GOEDDEL DAVID V
(Director) |
P | Common Stock | A | 26811 | $0.62 - $0.71 | $18,330 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |